Nepafenac.
出版信息
Aust Prescr. 2017 Dec;40(6):246-247. doi: 10.18773/austprescr.2017.071. Epub 2017 Oct 3.
Abstract
摘要
相似文献
1
Nepafenac.奈帕芬胺
Aust Prescr. 2017 Dec;40(6):246-247. doi: 10.18773/austprescr.2017.071. Epub 2017 Oct 3.
2
Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients.局部应用萘非那酸对糖尿病患者全视网膜光凝术后中心凹厚度的影响。
J Ophthalmol. 2017;2017:3765253. doi: 10.1155/2017/3765253. Epub 2017 Jun 27.
3
Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification.溴芬酸、奈帕芬胺与双氯芬酸钠预防白内障超声乳化术后黄斑囊样水肿的疗效及安全性比较研究
Int J Ophthalmol. 2018 Jul 18;11(7):1210-1216. doi: 10.18240/ijo.2018.07.22. eCollection 2018.
4
Development and validation of high performance liquid chromatography with a spectrophotometric detection method for the chemical purity and assay of nepafenac.开发并验证了高效液相色谱法，该方法具有分光光度检测，用于奈帕芬酸的化学纯度和含量测定。
J Pharm Biomed Anal. 2014 Mar;91:1-6. doi: 10.1016/j.jpba.2013.12.009. Epub 2013 Dec 19.
5
Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification.前列腺素E2抑制作用以及白内障超声乳化手术患者中0.4%酮咯酸（安贺拉LS）和0.1%奈帕芬胺（奈维敏）的房水浓度
Am J Ophthalmol. 2007 Jul;144(1):146-7. doi: 10.1016/j.ajo.2007.02.034.
6
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.萘普生、安芬那酸、酮咯酸和溴芬酸的体内药代动力学及体外药效学
J Cataract Refract Surg. 2007 Sep;33(9):1539-45. doi: 10.1016/j.jcrs.2007.05.015.
7
Comparative effects of the nonsteroidal anti-inflammatory drug nepafenac on corneal sensory nerve fibers responding to chemical irritation.非甾体抗炎药奈帕芬酸对角膜化学刺激敏感神经纤维的比较作用。
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):182-8. doi: 10.1167/iovs.06-0710.
8
Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification.萘非那酸对接受白内障超声乳化术的青光眼患者黄斑区形态的影响。
Int Ophthalmol. 2017 Oct;37(5):1147-1153. doi: 10.1007/s10792-016-0381-6. Epub 2016 Oct 22.
9
Comparison of the Tolerability of Diclofenac and Nepafenac.双氯芬酸与奈帕芬胺耐受性的比较。
J Ocul Pharmacol Ther. 2016 Nov;32(9):601-605. doi: 10.1089/jop.2016.0057. Epub 2016 Aug 11.
10
Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.局部应用奈帕芬酸可抑制糖尿病诱导的视网膜微血管疾病以及视网膜代谢和生理的潜在异常。
Diabetes. 2007 Feb;56(2):373-9. doi: 10.2337/db05-1621.
本文引用的文献
1
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study.一日一次地那非前列腺素滴眼液 0.3%用于预防和治疗白内障手术后眼部炎症和疼痛：3 期研究。
J Cataract Refract Surg. 2014 Feb;40(2):203-11. doi: 10.1016/j.jcrs.2013.07.042. Epub 2013 Dec 15.
Zotero 插件